Signal-dependent nuclear translocation of transcription factor nuclear fact
or kappa B (NF-kappa B) is required for the activation of downstream target
genes encoding the mediators of immune and inflammatory responses. To inhi
bit this inducible signaling to the nucleus, we designed a cyclic peptide (
cSN50) containing a cell-permeable motif and a cyclized form of the nuclear
localization sequence for the p50-NF-kappa B1 subunit of NF-kappa B. When
delivered into cultured macrophages treated with the pro-inflammatory agoni
st lipopolysaccharide, cSN50 was a more efficient inhibitor of NF-kappa B n
uclear import than its linear analog. When delivered into mice challenged w
ith lipopolysaccharide, cSN50 potently blocked the production of proinflamm
atory cytokines (tumor necrosis factor alpha and interferon gamma) and sign
ificantly reduced the lethality associated with ensuing endotoxic shock. Ba
sed on specificity studies conducted with a mutated form of cSN50, a functi
onal nuclear localization motif is required for this protective effect. Tak
en together, our findings demonstrate effective targeting of a cell-permeab
le peptide that attenuates cytokine signaling in vivo. This new class of bi
ological response modifiers may be applicable to the control of systemic in
flammatory reactions.